...
首页> 外文期刊>Eurosurveillance >Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
【24h】

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020

机译:SARS-COV-2感染过程中的血清学和分子结果:芬兰的第一种案例研究,1月至2月2020年

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins.
机译:芬兰冠状病毒病(Covid-19)的第一种情况是在2020年1月29日确认。未检测到次要病例。我们描述了自第一个症状以来3-23天的临床图和实验室结果。分离出SARS-COV-2 /芬兰/ 1/2020病毒菌株,该基因组显示出从武汉到参考菌株的单核苷酸取代。中和抗体应答在9天内出现,以及特定的IgM和IgG响应,靶向特别是核衣壳和尖峰蛋白。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号